Skip to content
Open in App
Active Biotech logo

Active Biotech

web2

Active Biotech is a Swedish biotechnology company developing experimental medicines for blood c...

Symbol ยท ACTI
Company profile

About

Active Biotech is a Swedish biotechnology company developing experimental medicines for blood cancers and inflammatory eye diseases, with clinical programs based on immunomodulation and targeted cancer treatment. Its lead candidate, tasquinimod, is being studied for myelofibrosis, a disorder affecting blood cell production in the bone marrow. The company is also developing laquinimod as an eye-drop treatment for inflammatory conditions such as noninfectious uveitis. Naptumomab, an investigational cancer immunotherapy for solid tumors, is licensed to a development partner. Active Biotech conducts development with clinical research collaborators rather than selling approved medicines from these programs.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeStockholmPrimary symbol: ACTI
Expert coverage

Active Biotech profile.

Orbitrum research

Expert coverage

No published expert evaluations are available for this project yet.

Orbitrum Academy

Learn how to read a project assessment